New considerations regarding pelvic organ prolapse treatment in China  

作　　者：ZHU Lan G.Willy Davila 

机构地区：[1]Department of Obstetrics and Gynecology,Peking Union Medical College Hospital,Beijing 100730,China [2]Department of Gynecology,Cleveland Clinic Florida,2950 Cleveland Clinic Boulevard,Weston,FL 33331,USA Department of Gynecology,Cleveland Clinic Florida,2950 Cleveland Clinic Boulevard,Weston,FL 33331,USA Department of Gynecology,Cleveland Clinic Florida,2950 Cleveland Clinic Boulevard,Weston,FL 33331,USA

出　　处：《Chinese Medical Journal》2012年第7期1209-1211,共3页中华医学杂志（英文版）

摘　　要：Pelvic organ prolapse （POP） is non-fatal conditions which can markedly affect a patient’s quality of life. Multiple recently developed pelvic reconstructive surgeries have led to a recent expansion in China. In this study, we would like to discuss various aspects of the evaluation and management of POP and raise the question of what is sufficient evidence for the adoption of innovative treatments for POP.Pelvic organ prolapse （POP） is non-fatal conditions which can markedly affect a patient’s quality of life. Multiple recently developed pelvic reconstructive surgeries have led to a recent expansion in China. In this study, we would like to discuss various aspects of the evaluation and management of POP and raise the question of what is sufficient evidence for the adoption of innovative treatments for POP.

关 键 词：pelvic organ prolapse UROGYNECOLOGY reconstructive surgery pelvic surgery MESH 

分 类 号：S512.1[农业科学—作物学] S858